Parvovirus B19-related anemia in HIV-infected patients

AIDS Patient Care and STDs

Volumn 14, Issue 1, 2000, Pages 7-11

  Koduri, Prasad Rao ^a,b  

^a Jr Hospital of Cook County   (United States)

^b The CORE Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN;

ADULT; ANEMIA; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; DOT HYBRIDIZATION; ERYTHROCYTE APLASIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOTHERAPY; LYMPHOCYTE COUNT; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; RELAPSE; SEROPREVALENCE; VIREMIA; VIRUS INFECTION;

ADULT; ERYTHEMA INFECTIOSUM; HIV INFECTIONS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; PARVOVIRUS B19, HUMAN; RED-CELL APLASIA, PURE;

EID: 0033958982     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/108729100318082     Document Type: Article

References (28)

1. Scadden D, Zon L, Groopman J. Pathophysiology and management of HIV-associated hematologic disorders. Blood 1989;74:1455-1463.
2. Zon L, Groopman J. Hematologic manifestations of the human immunodeficiency virus. Semin Hematol 1988;25:208-218.
3. Frickhofen N, Abkowitz JL, Safford M, Berry M, Antunez de Mayolo J, Astrow A, Cohen R, Halperin I, King L, Mintzer D, Cohen B, Young NS. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS. Ann Int Med 1990;113:926-933.
4. Young NS. Human parvovirus. In: Gorbach SL, Bartlett JG, Blacklow NR, eds. Infectious Diseases, 2nd ed. Philadelphia: W.B. Saunders, 1998, pp 2091-2098.
5. Prowse C, Ludlam CA, Yap PL. Human parvovirus B19 and blood products. Vox Sang 1997;72:1-10.
6. Kerr JR, Curran MD, Moore JE, Coyle PV, Ferguson WP. Persistent parvovirus B19 infection. Lancet 1995;345:1118.
7. Musiani M, Zerbini M, Gentilomi G, et al. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995;172:1360-1363.
8. Finkel TH, Török TJ, Ferguson PJ, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: Opportunistic infection or aetiological agent? Lancet 1994;343:1255-1258.
9. Bremner JAG, Beard S, Cohen BJ, Alimenti A, Cantiniaux B, Levy J. Secondary infection with parvovirus B19 in an HIV-positive patient. AIDS 1993;7: 1131-1132.
10. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: Cellular receptor for B19 parvovirus. Science 1993;262:114-117.
11. Koduri PR. Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection. Am J Hematol 1998;58:95-99.
12. Brown KE, Young NS. Persistent parvovirus B19 infection. Rev Med Microbiol 1995;6:246-256.
13. Seyama K, Kobayashi R, Hasle H, Apter AJ, Rutledge JC, Rosen D, Ochs HD. Parvovirus B19-induced anemia as the presenting manifestation of X-linked hyper-IgM syndrome. J Infect Dis 1998;178:318-324.
14. van Elsacker-Niele AMW, Kroon FP, van der Ende ME, Salimans MMM, Spaan WJM, Kroes ACM. Prevalence of parvovirus B19 infection in patients with human immunodeficiency virus. Clin Infect Dis 1996; 23:1255-1260.
15. Vernazza PL, Pfister LA, Siegl G, Cassinotti P. High seroprevalence of parvovirus B19 among patients infected with human immunodeficiency virus (letter). Clin Infect Dis 1996;22:198-199.
16. Chernak E, Dubin G, Henry D, Naides SJ, Hodinka RL, MacGregor RR, Friedman HM. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 1995;20: 170-173.
17. Söderlund M, von Essen R, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet 1997; 349:1063-1065.
18. Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997;53:229-232.
19. Kerr JR, Kane D, Crowley B, Leonard N, O'Briain S, Coyle PV, Mulcahy F. Parvovirus B19 infection in AIDS patients. Int J STD AIDS 1997;8:184-186.
20. Naides SJ, Howard EJ, Swack NS, True CA, Strapleton JT. Parvovirus B19 infection in human immunodeficiency virus type I-infected persons failing or intolerant to zidovudine. J Infect Dis 1993;168: 101-105.
21. Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS. Clinical relevance of parovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 1997;176: 269-273.
22. Koduri PR, Kumapley R, Khokha ND. Nondiagnostic bone marrow in parvovirus B19-related anemia in AIDS: confounding effect of prior transfusion? J Infect Dis 1998;177:1773.
23. Bowman CA, Cohen BJ, Norfolk DR, Lacey CJN. Red cell aplasia associated with human parvovirus B19 and HIV infection: failure to respond clinically to intravenous immunoglobulin. AIDS 1990;10:1038-1039.
24. Koduri PR, Kumapley R, Valladares J, Teter C. Chronic pure red cell aplasia caused by parvovirus B19 in AIDS: Use of I.V. immunoglobulin. A report of 8 cases. Am J Hematol. 1998;61:16-20.
25. Goedert JJ, Erdman DD, Konkle BA, et al. Parvovirus B19 quiescence during the course of human immunodeficiency virus infection in persons with hemophilia. Am J Hematol 1997;56:248-251.
26. Antunez de Mayolo J, Temple D. Pure red cell aplasia due to parvovirus B19 infection in a man with HIV infection. South Med J 1990;83:1480-1481.
27. Griffin TC, Squires JE, Timmons CF, Buchanan GR. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection. J Pediatr 1991;118: 899-901.
28. Nguyen QT, Sifer C, Schneider V, Bernaudin F, Auguste V, Garbarg-Chenon A. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia. Lancet 1998;352:1524.